Vancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer (scientific article)

Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study

Q22305307

Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin

Q31954126

Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin

Q33750776

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria

Q33756519

Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia

Q33756523

The murMN operon: a functional link between antibiotic resistance and antibiotic tolerance in Streptococcuspneumoniae

Q34010162

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

Q34114674

Infectious morbidity in critically ill patients with cancer

Q34348047

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

Q34783668

Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model

Q35013754

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

Q43433837

Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients

Q43723782

Bacteremia due to viridans streptococci in neutropenic patients

Q44160196

Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers

Q44273248

Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States

Q44417864

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

Q44863798

Signal transduction by a death signal peptide: uncovering the mechanism of bacterial killing by penicillin

Q47878599

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

vancomycin

Q424027

gram-positive bacteria

Q857288

P304

page(s)

1815-1820

P577

publication date

2006-04-01

P1433

published in

Cancer

Q326041

P1476

title

Vancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer

P478

volume

106

Reverse relations

cites work (P2860)

Q33559083	A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii
Q36972978	Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates
Q40224839	Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).
Q38926289	Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.
Q40252885	In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients
Q42215430	In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients
Q37190789	Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007.
Q90226085	Mutations in cdsA and pgsA Correlate with Daptomycin Resistance in Streptococcus mitis and S. oralis
Q37537353	New antimicrobial agents for the treatment of bacterial infections in cancer patients
Q40361170	Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococcus mitis/oralis by a Novel Mechanism
Q53695835	Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies.
Q42743418	Role of daptomycin in the treatment of infections in patients with hematological malignancies
Q37377897	Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).
Q38131442	The current spectrum of infection in cancer patients with chemotherapy related neutropenia.
Q46457973	Vancomycin flush as antibiotic prophylaxis for early catheter-related infections: a cost-effectiveness analysis
Q35203343	Vancomycin tolerant, methicillin-resistant Staphylococcus aureus reveals the effects of vancomycin on cell wall thickening
Q36839712	Vancomycin: does it still have a role as an antistaphylococcal agent?

P356	DOI	10.1002/CNCR.21801
P698	PubMed publication ID	16534785